1. | djmanicmusic | |
2. | seam23 | |
3. | mrwhite14 | |
4. | kaalm | |
5. | heppnerda |
1. | djmanicmusic | |
2. | seam23 | |
3. | mrwhite14 | |
4. | kaalm | |
5. | heppnerda |
1. | seam23 03/29/2018 Shares under pressure on news of Pfizer approval and potential competition for patisiran |
2. | seam23 01/25/2018 Leerink Partners raises PT to $135 from $132 |
3. | mrwhite14 06/04/2018 FDA has granted Orphan Drug Designation to ALN-TTRsc02 |
4. | djmanicmusic 07/27/2018 CHMP has adopted a Positive Opinion recommending marketing authorization of patisiran |
5. | djmanicmusic 05/03/2018 Finally reached alignment with the FDA on a pivotal study design for lumasiran |
6. | seam23 02/08/2018 Beats EPS loss estimates by $0.19 and beats on revenues |
7. | mrwhite14 02/09/2018 Morgan Stanley |
8. | mrwhite14 04/16/2018 Alnylam Presents New Positive Clinical Results for Givosiran, an Investigational RNAi Therapeutic for the Treatment of Acute Hepatic Porphyrias |
9. | mrwhite14 03/26/2018 These 12 Drugs Launching In 2018 Are Headed For Blockbuster Status |
10. | djmanicmusic 04/20/2018 Dicerna Pharmaceuticals has resolved all litigation with Alnylam Pharmaceuticals |